col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


63 Results       Page 1

 [1] 
Microbiology Society: Journal of General Virology
  original article Date Title Authors   All Authors
1 [GO] 2025―Apr―04 Distribution of aminopeptidase N coronavirus receptors in the respiratory and digestive tracts of domestic and wild artiodactyls and carnivores Fabian Z.X. Lean, Giulia Gallo, Joseph Newman, Stuart Ackroyd, Simon Spiro, Ruth Cox, et al. (+13)
2 [GO] 2025―Feb―13 Comparative syncytia formation dynamics of coronavirus MHV-A59 and pneumovirus hRSV A2 and incorporation into improved kinetic virus replication models Emily H. Landwehr, Lyla R. Vivian, George G. Papadeas, Ethan J. White, Jayden M. Doster, Nicholas R. Brenner, et al. (+8)
3 [GO] 2025―Feb―12 Examining the feasibility of replacing ORF3a with fluorescent genes to construct SARS-CoV-2 reporter viruses Isobel Webb, Maximillian Erdmann, Rachel Milligan, Megan Savage, David A. Matthews, Andrew D. Davidson
4 [GO] 2025―Jan―30 Linking the function of cis-acting RNA elements to coronavirus replication using interactomes Yueh-Chun Yao, Chun-Chun Yang, Meilin Wang, Feng-Cheng Hsieh, Ching-Hung Lin, Hsuan-Wei Hsu, et al. (+5)
5 [GO] 2025―Jan―13 HIV capsids: orchestrators of innate immune evasion, pathogenesis and pandemicity Kate L. Morling, Mohamed ElGhazaly, Richard S. B. Milne, Greg J. Towers
6 [GO] 2025―Jan―09 A yeast-assembled, plasmid-launched reverse genetics system for the murine coronavirus MHV-A59 Cade E. Sterling, Natalie R. Wilson, Debreiona Y. Harris, Everett Clinton Smith
7 [GO] 2024―Dec―20 Comparison of different T cell assays for the retrospective determination of SARS-CoV-2 infection Benjamin Krishna, Marina Metaxaki, Marianne Perera, Mark Wills, Nyarie Sithole
8 [GO] 2024―Oct―30 BALB/c mice challenged with SARS-CoV-2 B.1.351 β variant cause pathophysiological and neurological changes within the lungs and brains Panatda Saenkham-Huntsinger, Aleksandra K. Drelich, Pinghan Huang, Bi-Hung Peng, Chien-Te K. Tseng
9 [GO] 2024―Sep―18 SARS-CoV-2 infection and transmission via the skin to oro-nasal route with the production of bioaerosols in the ferret model Rebecca Shipley, Amanda H. Seekings, Alexander M.P. Byrne, Shweta Shukla, Joe James, Hooman Goharriz, et al. (+5)
10 [GO] 2024―Aug―19 Diversifying selection identified in immune epitopes of bovine coronavirus isolates from Irish cattle Tristan Russell, Jose Maria Lozano, Cailyn Challinor, Gerald Barry
11 [GO] 2024―Jul―12 SARS-CoV-2 infects neurons, astrocytes, choroid plexus epithelial cells and pericytes of the human central nervous system in vitro Ruth Haverty, Janet McCormack, Christopher Evans, Kevin Purves, Sophie O'Reilly, Virginie Gautier, et al. (+3)
12 [GO] 2024―May―22 Role of N-linked glycosylation in porcine reproductive and respiratory syndrome virus (PRRSV) infection Raymond R.R. Rowland, Alberto Brandariz-Nuñez
13 [GO] 2024―May―08 Assessing the change in the epidemiology of seasonal respiratory viruses with the onset of the COVID-19 pandemic Yalcin Kara, Mahmut Can Kizil, Merve İşeri Nepesov, Ebru Kaçmaz, Eylem Kiral, Gurkan Bozan, et al. (+4)
14 [GO] 2024―Jan―25 Enhancement of cellular immunity following needle-free vaccination of mice with SARS-CoV-2 spike protein Christopher L. D. McMillan, Danushka K. Wijesundara, Jovin J. Y. Choo, Alberto A. Amarilla, Naphak Modhiran, Germain J. P. Fernando, et al. (+4)
15 [GO] 2023―Dec―07 Lack of detection of SARS-CoV-2 in British wildlife 2020-21 and first description of a stoat (Mustela erminea) Minacovirus Ternenge Apaa, Amy J. Withers, Laura Mackenzie, Ceri Staley, Nicola Dessi, Adam Blanchard, et al. (+9)
16 [GO] 2023―Nov―24 Evolution of the coronavirus spike protein in the full-length genome and defective viral genome under diverse selection pressures Ching-Hung Lin, Hon-Man-Herman Tam, Cheng-Yao Yang, Feng-Cheng Hsieh, Jiun-Long Wang, Chun-Chun Yang, et al. (+3)
17 [GO] 2023―Nov―10 SARS-CoV-2 and the DNA damage response Roger J. Grand
18 [GO] 2023―Oct―10 Desmoglein-2 and COVID-19 complications: insights into its role as a biomarker, pathogenesis and clinical implications Chidiebere F. Uchechukwu, Uchechukwu Love Anyaduba, Chukwuemeka Chinedum Udekwu, Oluwatosin Qawiyy Orababa, Ayomikun Emmanuel Kade
19 [GO] 2023―Oct―06 MERS-CoV and SARS-CoV-2 membrane proteins are modified with polylactosamine chains Dylan Juckel, Lowiese Desmarets, Adeline Danneels, Yves Rouillé, Jean Dubuisson, Sandrine Belouzard
20 [GO] 2023―Aug―31 A novel chimeric vaccine candidate for porcine reproductive and respiratory syndrome virus (PRRSV) I and II elicits neutralizing antibodies against both types Sang-Ho Cha, Bang-Hun Hyun, Hyang-Sim Lee, Seok-Jin Kang, Su-Hwa You, Jiwoon Jeong, et al. (+3)
21 [GO] 2023―Aug―31 Continued adaptation of A/H2N2 viruses during pandemic circulation in humans Jasmin S. Kutter, Martin Linster, Dennis de Meulder, Theo M. Bestebroer, Pascal Lexmond, Miruna E. Rosu, et al. (+4)
22 [GO] 2023―Jul―26 Corrigendum: Inhibition of phosphodiesterase 12 results in antiviral activity against several RNA viruses including SARS-CoV-2 Mark Thursz, Fouzia Sadiq, Julia A. Tree, Peter Karayiannis, David W. C. Beasley, Wanwissa Dejnirattisai, et al. (+7)
23 [GO] 2023―Jul―11 Inhibition of phosphodiesterase 12 results in antiviral activity against several RNA viruses including SARS-CoV-2 Mark Thursz, Fouzia Sadiq, Julia A. Tree, Peter Karayiannis, David W. C. Beasley, Wanwissa Dejnirattisai, et al. (+7)
24 [GO] 2023―Jun―21 ARF6 is a host factor for SARS-CoV-2 infection in vitro C. Mirabelli, J. Bragazzi Cunha, J. W. Wotring, E. J. Sherman, J. El Saghir, J. Harder, et al. (+4)
25 [GO] 2023―May―11 Plasma after both SARS-CoV-2 boosted vaccination and COVID-19 potently neutralizes BQ.1.1 and XBB.1 David J. Sullivan, Massimo Franchini, Jonathon W. Senefeld, Michael J. Joyner, Arturo Casadevall, Daniele Focosi
26 [GO] 2023―Feb―17 The health of influenza surveillance and pandemic preparedness in the wake of the COVID-19 pandemic Rodney Stuart Daniels, John William McCauley
27 [GO] 2023―Feb―14 A novel antiviral formulation containing caprylic acid inhibits SARS-CoV-2 infection of a human bronchial epithelial cell model Kevin Purves, Ruth Haverty, Tiina O'Neill, David Folan, Sophie O'Reilly, Alan W. Baird, et al. (+5)
28 [GO] 2022―Nov―22 Infectious droplet exposure is an inefficient route for SARS-CoV-2 infection in the ferret model Joe James, Alexander M. P. Byrne, Hooman Goharriz, Megan Golding, Joan M. A. Cuesta, Benjamin C. Mollett, et al. (+4)
29 [GO] 2022―Oct―25 Retraction notice: The middle half genome of interferon-inducing porcine reproductive and respiratory syndrome virus strain A2MC2 is essential for interferon induction
30 [GO] 2022―May―04 Mutations within scavenger receptor cysteine-rich (SRCR) protein domain 5 of porcine CD163 involved in infection with porcine reproductive and respiratory syndrome virus (PRRS) Ana M. M. Stoian, Raymond R. R. Rowland, Alberto Brandariz-Nuñez
31 [GO] 2022―Apr―04 SARS-CoV-2 variants of concern alpha, beta, gamma and delta have extended ACE2 receptor host ranges Nazia Thakur, Giulia Gallo, Joseph Newman, Thomas P. Peacock, Luca Biasetti, Catherine N. Hall, et al. (+3)
32 [GO] 2022―Jan―11 Selection and T-cell antigenicity of synthetic long peptides derived from SARS-CoV-2 Katarzyna Piadel, Amin Haybatollahi, Angus George Dalgleish, Peter Lawrence Smith
33 [GO] 2021―Nov―24 Antibodies specific to SARS-CoV-2 proteins N, S and E in COVID-19 patients in the normal population and in historical samples Aleksander Szymczak, Natalia Jędruchniewicz, Alessandro Torelli, Agata Kaczmarzyk-Radka, Rosa Coluccio, Marlena Kłak, et al. (+7)
34 [GO] 2021―Nov―17 Infection in asymptomatic carriers of SARS-CoV-2 can interfere with the achievement of robust immunity on a population scale Kelvinson Viana, Luis Zarpelon, Andre Leandro, Maria Terencio, Renata Lopes, Caroline Martins, et al. (+11)
35 [GO] 2021―Oct―27 MERS-CoV infection causes brain damage in human DPP4-transgenic mice through complement-mediated inflammation Yuting Jiang, Yuehong Chen, Hong Sun, Xiaolu Zhang, Lei He, Jiangfan Li, et al. (+2)
36 [GO] 2021―Oct―08 Head-to-head evaluation of seven different seroassays including direct viral neutralisation in a representative cohort for SARS-CoV-2 Laura Olbrich, Noemi Castelletti, Yannik Schälte, Mercè Garí, Peter Pütz, Abhishek Bakuli, et al. (+27)
37 [GO] 2021―Sep―15 Prevalence and molecular characteristics of feline coronavirus in southwest China from 2017 to 2020 Qun Zhou, Yan Li, Jian Huang, Nengsheng Fu, Xin Song, Xue Sha, Bin Zhang
38 [GO] 2021―Aug―23 Analysis of the avian coronavirus spike protein reveals heterogeneity in the glycans present Phoebe Stevenson-Leggett, Stuart Armstrong, Sarah Keep, Paul Britton, Erica Bickerton
39 [GO] 2021―Jul―28 Combined computational and cellular screening identifies synergistic inhibition of SARS-CoV-2 by lenvatinib and remdesivir Marie O. Pohl, Idoia Busnadiego, Francesco Marrafino, Lars Wiedmer, Annika Hunziker, Sonja Fernbach, et al. (+5)
40 [GO] 2021―Jun―16 Retrospective screening of routine respiratory samples revealed undetected community transmission and missed intervention opportunities for SARS-CoV-2 in the United Kingdom Joseph G. Chappell, Theocharis Tsoleridis, Gemma Clark, Louise Berry, Nadine Holmes, Christopher Moore, et al. (+18)
41 [GO] 2021―May―06 Differential role of sphingomyelin in influenza virus, rhinovirus and SARS-CoV-2 infection of Calu-3 cells Thrimendra Kaushika Dissanayake, Bingpeng Yan, Anthony Chin-Ki Ng, Hanjun Zhao, Gabriella Chan, Cyril Chik-Yan Yip, et al. (+2)
42 [GO] 2021―May―06 SARS-CoV-2 replicon for high-throughput antiviral screening Qiu-Yan Zhang, Cheng-Lin Deng, Jing Liu, Jia-Qi Li, Hong-Qing Zhang, Na Li, et al. (+5)
43 [GO] 2021―Apr―29 Effective in vitro inactivation of SARS-CoV-2 by commercially available mouthwashes Katherine Davies, Hubert Buczkowski, Stephen R. Welch, Nicole Green, Damian Mawer, Neil Woodford, et al. (+4)
44 [GO] 2021―Apr―23 Investigative study into whether an insect repellent has virucidal activity against SARS-CoV-2 Sophie J. Smither, Lin S. Eastaugh, James S. Findlay, Thomas R. Laws, Stephen N. Marriott, Stuart Notman, et al. (+7)
45 [GO] 2021―Apr―15 SARS-CoV-2 one year on: evidence for ongoing viral adaptation Thomas P. Peacock, Rebekah Penrice-Randal, Julian A. Hiscox, Wendy S. Barclay
46 [GO] 2021―Apr―08 The green tea catechin epigallocatechin gallate inhibits SARS-CoV-2 infection Lisa Henss, Arne Auste, Christoph Schürmann, Christin Schmidt, Christine von Rhein, Michael D. Mühlebach, Barbara S. Schnierle
47 [GO] 2021―Feb―22 Hamster and ferret experimental infection with intranasal low dose of a single strain of SARS-CoV-2 Elodie Monchatre-Leroy, Sandrine Lesellier, Marine Wasniewski, Evelyne Picard-Meyer, Céline Richomme, Franck Boué, et al. (+8)
48 [GO] 2021―Feb―15 A comprehensive profile of genomic variations in the SARS-CoV-2 isolates from the state of Telangana, India Asmita Gupta, Radhakrishnan Sabarinathan, Pratyusha Bala, Vinay Donipadi, Divya Vashisht, Madhumohan Rao Katika, et al. (+4)
49 [GO] 2021―Jan―28 Targeting novel structural and functional features of coronavirus protease nsp5 (3CLpro, Mpro) in the age of COVID-19 Molly K. Roe, Nathan A. Junod, Audrey R. Young, Dia C. Beachboard, Christopher C. Stobart
50 [GO] 2021―Jan―11 A genetic element in the SARS-CoV-2 genome is shared with multiple insect species Torstein Tengs, Charles F. Delwiche, Christine Monceyron Jonassen
51 [GO] 2021―Jan―08 Assessment of inactivation procedures for SARS-CoV-2 Heidi Auerswald, Sokhoun Yann, Sokha Dul, Saraden In, Philippe Dussart, Nicholas J. Martin, et al. (+2)
52 [GO] 2020―Dec―17 Understanding the outcomes of COVID-19 - does the current model of an acute respiratory infection really fit? Peter Simmonds, Sarah Williams, Heli Harvala
53 [GO] 2020―Nov―05 Lysine 164 is critical for SARS-CoV-2 Nsp1 inhibition of host gene expression Zhou Shen, Guangxu Zhang, Yilin Yang, Mengxia Li, Siqi Yang, Guiqing Peng
54 [GO] 2020―Sep―30 Microbiology Society online workshop on SARS-CoV-2 and COVID-19, Wednesday 29 July 2020 Mark Harris
55 [GO] 2020―Sep―09 Predicting the recombination potential of severe acute respiratory syndrome coronavirus 2 and Middle East respiratory syndrome coronavirus Arinjay Banerjee, Andrew C. Doxey, Benjamin J.-M. Tremblay, Michael J. Mansfield, Sonu Subudhi, Jeremy A. Hirota, et al. (+4)
56 [GO] 2020―Sep―09 Analysis of partial sequences of the RNA-dependent RNA polymerase gene as a tool for genus and subgenus classification of coronaviruses David A. Wilkinson, Léa Joffrin, Camille Lebarbenchon, Patrick Mavingui
57 [GO] 2020―Sep―07 Construction and efficacy evaluation of novel swine leukocyte antigen (SLA) class I and class II allele-specific poly-T cell epitope vaccines against porcine reproductive and respiratory syndrome virus Debin Tian, Sakthivel Subramaniam, C. Lynn Heffron, Hassan M. Mahsoub, Harini Sooryanarain, Bo Wang, et al. (+6)
58 [GO] 2020―Aug―21 SARS-CoV-2 growth, furin-cleavage-site adaptation and neutralization using serum from acutely infected hospitalized COVID-19 patients William B. Klimstra, Natasha L. Tilston-Lunel, Sham Nambulli, James Boslett, Cynthia M. McMillen, Theron Gilliland, et al. (+9)
59 [GO] 2020―Jul―28 Multiple novel non-canonically transcribed sub-genomic mRNAs produced by avian coronavirus infectious bronchitis virus Sarah Keep, Michael S. Oade, Filip Lidzbarski-Silvestre, Kirsten Bentley, Phoebe Stevenson-Leggett, Graham L. Freimanis, et al. (+6)
60 [GO] 2020―Jul―15 A putative new SARS-CoV protein, 3c, encoded in an ORF overlapping ORF3a Andrew E. Firth
61 [GO] 2020―Jun―24 Insights into SARS-CoV-2, the Coronavirus Underlying COVID-19: Recent Genomic Data and the Development of Reverse Genetics Systems Severino Jefferson Ribeiro da Silva, Renata Pessôa Germano Mendes, Caroline Targino Alves da Silva, Alessio Lorusso, Alain Kohl, Lindomar Pena
62 [GO] 2020―Jun―15 Molecular simulation of SARS-CoV-2 spike protein binding to pangolin ACE2 or human ACE2 natural variants reveals altered susceptibility to infection Jingfang Wang, Xintian Xu, Xinbo Zhou, Ping Chen, Huiying Liang, Xuan Li, et al. (+2)
63 [GO] 2020―May―20 The dynamics of humoral immune responses following SARS-CoV-2 infection and the potential for reinfection Paul Kellam, Wendy Barclay
 [1] 

63 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.004 sec